α-Lipoic acid suppresses the development of DNFB-induced atopic dermatitis-like symptoms in NC/Nga mice

Experimental Dermatology

Volumn 20, Issue 2, 2011, Pages 97-101

  Kim, Gun Dong ^a   Kim, Tae Ho ^a   Jang, An Hee ^a   Ahn, Hyun Jong ^a   Park, Yong Seek ^a   Park, Cheung Seog ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Lipoic acid; 2 4 dinitrofluorobenzene; Atopic dermatitis; CD4 + T cells; NC Nga

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ANTIOXIDANT; DIHYDROLIPOATE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; METAL ION; REACTIVE OXYGEN METABOLITE; SCAVENGER; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIUM; CD4+ T LYMPHOCYTE; CHELATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MAMMAL; MOUSE; NONHUMAN; SKIN DEFECT; YEAST;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DERMATITIS, ATOPIC; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MICE; MICE, INBRED STRAINS; THIOCTIC ACID;

EID: 78751693546     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01165.x     Document Type: Article

References (38)

1. Leung D Y. J Allergy Clin Immunol 2000: 105: 860-876.
2. Leung D Y, Bieber T. Lancet 2003: 361: 151-160.
3. Ong P Y. Expert Opin Emerg Drugs 2009: 14: 165-179.
4. Novak N, Bieber T, Leung D Y. J Allergy Clin Immunol 2003: 112: S128-S139.
5. Fedenko E. Pol Merkur Lekarski 2003: 14: 602-604.
6. Jin H, He R, Oyoshi M et al. J Invest Dermatol 2009: 129: 31-40.
7. Galli E, Cicconi R, Rossi P et al. Curr Mol Med 2003: 3: 127-138.
8. Lee S J, Oh S G, Seo S W et al. Biol Pharm Bull 2007: 30: 1468-1471.
9. Vestergaard C, Yoneyama H, Matsushima K. Mol Med Today 2000: 6: 209-210.
10. Suto H, Matsuda H, Mitsuishi K et al. Int Arch Allergy Immunol 1999: 120 (Suppl 1): 70-75.
11. Grimstad O, Sawanobori Y, Vestergaard C et al. Exp Dermatol 2009: 18: 35-43.
12. Tomimori Y, Tanaka Y, Goto M et al. J Invest Dermatol 2005: 124: 119-124.
13. Heylings J R, Clowes H M, Cumberbatch M et al. Toxicology 1996: 109: 57-65.
14. Packer L, Witt E H, Tritschler H J. Free Radic Biol Med 1995: 19: 227-250.
15. Gunther S, Storm J, Muller S. Int J Biochem Cell Biol 2009: 41: 748-752.
16. Shay K P, Moreau R F, Smith E J et al. Biochim Biophys Acta 2009: 1790: 1149-1160.
17. Cho Y S, Lee J, Lee T H et al. J Allergy Clin Immunol 2004: 114: 429-435.
18. Venkatraman M S, Chittiboyina A, Meingassner J et al. Arch Dermatol Res 2004: 296: 97-104.
19. Oranje A P, Glazenburg E J, Wolkerstorfer A et al. Br J Dermatol 2007: 157: 645-648.
20. Sasakawa T, Higashi Y, Sakuma S et al. Int Arch Allergy Immunol 2001: 126: 239-247.
21. Lee S H, Lee S E, Ahn H J et al. Mol Cell Toxicol 2009: 5: 113-119.
22. Ho Y S, Lai C S, Liu H I et al. Biochem Pharmacol 2007: 73: 1786-1795.
23. Kim T H, Jung J A, Kim G D et al. J Pineal Res 2009: 47: 324-329.
24. Kim D Y, Jung J A, Kim T H et al. J Ethnopharmacol 2009: 122: 567-572.
25. Matsumoto M, Ra C, Kawamoto K et al. J Immunol 1999: 162: 1056-1063.
26. Rajka G. Clin Rev Allergy 1986: 4: 3-26.
27. Rudikoff D, Lebwohl M. Lancet 1998: 351: 1715-1721.
28. Spergel J M, Mizoguchi E, Oettgen H et al. J Clin Invest 1999: 103: 1103-1111.
29. Abbas A K, Murphy K M, Sher A. Nature 1996: 383: 787-793.
30. Salinthone S, Schillace R V, Marracci G H et al. J Neuroimmunol 2008: 199: 46-55.
31. Tanaka M, Aiba S, Matsumura N et al. Arch Dermatol 1994: 130: 1393-1401.
32. Kang J S, Yoon W K, Youm J K et al. Exp Dermatol 2008: 17: 958-964.
33. Matsuda H, Watanabe N, Geba G P et al. Int Immunol 1997: 9: 461-466.
34. Deane J A, Hickey M J. Expert Rev Mol Med 2009: 11: e25.
35. Shibata S, Maeda S, Chimura N et al. Res Vet Sci 2009: 88: 422-426.
36. Rahman I. J Biochem Mol Biol 2003: 36: 95-109.
37. Henderson W R Jr, Chi E Y, Teo J L et al. J Immunol 2002: 169: 5294-5299.
38. Wang X, Zhang X, Cheng Y et al. Neurotoxicology 2009: 31: 101-112.